Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 116 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Changes in Knee Articular Cartilage Volume in Women on Aromatase Inhibitors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Diagnostic, Supportive care, Treatment				Active				40 to 65				Other				2004/949 NCT00111241


2.		STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing Pilot)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				18 and over				Other				STARS-Pilot (05/55 Graham) NCT00126360


3.		Aromatase Inhibitor Clinical Trial

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Biomarker/Laboratory analysis, Treatment				Active				40 to 70				NIGMS				0412-14 UO1-GM61373-06, NCT00228956


4.		Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				18 and over				Pharmaceutical / Industry				CFEM345C2403 NCT00171847


5.		Arimidex Neoadjuvant in Operable Breast Cancer in Post-Menopausal Women

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				Postmenopausal to 65				Pharmaceutical / Industry				1033MX/001 NCT00262535


6.		Arthralgia During Anastrozole Therapy for Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				18 and over				Pharmaceutical / Industry				D5392L00013 2005-00-5441-19 EUDRACT number, NCT00323479


7.		Liver Safety Under Upfront Arimidex vs Tamoxifen

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				Not specified				Pharmaceutical / Industry				D5392L00023 NCT00537771


8.		Rheumatological Evaluation of Anastrozole and Letrozole as Adjuvant Treatment in Post-Menopausal Women With Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				50 and over				Pharmaceutical / Industry				CFEM345DUS59 NCT00688909


9.		Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				Postmenopausal				Pharmaceutical / Industry				CZOL446GDE19 NCT00375752


10.		Second-Line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				not specified				Other				N07MAN Eudract 2007-007030-20, NCT00684216

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute